?
內(nèi)容及儲存
?
Storage conditions: 2-8°C. Protect from light.
Shipping conditions: Ambient.
Shelf life: 18 months from date of manufacture.
?
描述
?
Opti-MEM? Reduced-Serum Medium is an improved Minimal Essential Medium (MEM) that allows for a reduction of Fetal Bovine Serum supplementation by at least 50% with no change to growth rate or morphology. Opti-MEM? is also recommended for use with cationic lipid transfection reagents, such as Lipofectamine? reagent. Opti-MEM? can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts. Life Technologies offers a variety of Gibco? Opti-MEM? modifications for a range of cell culture applications. This Opti-MEM? is modified as follows:
The complete formulation is confidential. For more information, please contact Technical Services.Gibco? Opti-MEM? is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.Product Intended UseFor in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law.cGMP Manufacturing and Quality SystemGibco? Opti-MEM? is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 and ISO 9001 standards. For supply chain continuity, Life Technologies offers an identical Gibco? Opti-MEM? product made in our Scotland facility (31985-047). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.Gibco? Opti-MEM? uses a sodium bicarbonate buffer system (2.4 g / L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.在中國境內(nèi), 本產(chǎn)品僅限于非臨床科研用途, 產(chǎn)品信息以中文為準(zhǔn)。 (In China territory, the product is for Research Use only in non-clinical unit, product information in Chinese shall prevail.)